Cellectis S.A. Stock Other OTC
Equities
CMVLF
FR0010425595
Biotechnology & Medical Research
Sales 2024 * | 16.19M 17.56M 23.99M | Sales 2025 * | 70.57M 76.55M 105M | Capitalization | 245M 266M 363M |
---|---|---|---|---|---|
Net income 2024 * | -74M -80.27M -110M | Net income 2025 * | -71M -77.01M -105M | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | 573K 622K 849K | Net cash position 2025 * | 180M 195M 266M | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Cellectis S.A.
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 18-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
1st Jan change | Capi. | |
---|---|---|
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |